GIANNINI, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.004
EU - Europa 4.625
AS - Asia 3.488
SA - Sud America 344
AF - Africa 98
OC - Oceania 79
Continente sconosciuto - Info sul continente non disponibili 4
Totale 17.642
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.924
RU - Federazione Russa 2.042
SG - Singapore 1.013
HK - Hong Kong 714
CN - Cina 681
IE - Irlanda 527
SE - Svezia 451
PL - Polonia 422
VN - Vietnam 352
BR - Brasile 279
KR - Corea 278
IT - Italia 259
DE - Germania 196
UA - Ucraina 187
FI - Finlandia 174
FR - Francia 157
GB - Regno Unito 110
TR - Turchia 107
IN - India 104
JP - Giappone 90
AU - Australia 77
CA - Canada 46
CI - Costa d'Avorio 42
BD - Bangladesh 29
AR - Argentina 26
NL - Olanda 21
BE - Belgio 17
IQ - Iraq 17
MX - Messico 17
CH - Svizzera 12
JO - Giordania 12
AE - Emirati Arabi Uniti 11
ID - Indonesia 11
NG - Nigeria 11
PK - Pakistan 11
ZA - Sudafrica 11
CO - Colombia 10
EC - Ecuador 9
ES - Italia 9
UZ - Uzbekistan 8
AZ - Azerbaigian 7
MA - Marocco 7
SA - Arabia Saudita 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
KE - Kenya 6
LT - Lituania 6
MY - Malesia 6
RO - Romania 6
EG - Egitto 5
JM - Giamaica 5
PH - Filippine 5
SC - Seychelles 5
CL - Cile 4
DZ - Algeria 4
EU - Europa 4
DK - Danimarca 3
DO - Repubblica Dominicana 3
IL - Israele 3
KG - Kirghizistan 3
KZ - Kazakistan 3
NO - Norvegia 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
UY - Uruguay 3
BO - Bolivia 2
CR - Costa Rica 2
GD - Grenada 2
GR - Grecia 2
MT - Malta 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
TH - Thailandia 2
TW - Taiwan 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
HN - Honduras 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MM - Myanmar 1
MN - Mongolia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
SI - Slovenia 1
Totale 17.640
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.247
Singapore 697
Ashburn 696
Fairfield 674
Hong Kong 588
Chandler 542
Dublin 527
Warsaw 420
San Jose 419
Cambridge 311
Seattle 300
Woodbridge 289
Seoul 278
Jacksonville 265
Wilmington 255
Beijing 239
Houston 236
The Dalles 190
Buffalo 176
Ann Arbor 161
Princeton 136
Lauterbourg 111
Los Angeles 107
Boardman 106
Boston 100
Ho Chi Minh City 99
Izmir 93
Altamura 91
Tokyo 90
Hanoi 87
Lawrence 80
Melbourne 76
Mumbai 72
Medford 62
Dallas 53
Hefei 48
Bremen 43
Abidjan 42
Shanghai 42
San Diego 39
Munich 38
Moscow 35
New York 34
Falls Church 26
Norwalk 25
Helsinki 23
Paris 23
São Paulo 22
Redondo Beach 21
Toronto 21
Da Nang 19
Florence 19
Milan 18
Brussels 17
Andover 16
Washington 16
Hillsboro 15
Orem 15
Turku 15
Chicago 13
Dearborn 13
Frankfurt am Main 13
Atlanta 12
Brooklyn 12
Abuja 11
Auburn Hills 11
Bern 11
Kent 11
London 11
Haiphong 10
Baghdad 9
Denver 9
Guangzhou 9
Porto Alegre 9
Old Bridge 8
Salerno 8
Stockholm 8
Tashkent 8
West Jordan 8
Brasília 7
Dhaka 7
Frankfurt Am Main 7
Rio de Janeiro 7
Rome 7
Verona 7
Curitiba 6
Dong Ket 6
Hải Dương 6
Montreal 6
Nha Trang 6
Phoenix 6
Amman 5
Baku 5
Belo Horizonte 5
Brno 5
Chennai 5
Johannesburg 5
Kuala Lumpur 5
Laurel 5
Manchester 5
Totale 11.832
Salva come PNG Salva come JPEG
Nome #
Hepatitis C Virus infection in the immunocompromised host: a complex scenario with variable clinical impact 323
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 315
HCV and lymphoproliferation 272
HCV Patients Psychopathology and Tryptophan Metabolism: Analysis of the Effects of Pegylated Interferon plus Ribavirin Treatment 245
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 219
Association Between Persistent Lymphatic Infection By Hepatitis C Virus After Antiviral Treatment And Mixed Cryoglobulinemia 207
Host genetic determinants in HCV-related mixed cryoglobulinemia 198
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators 197
Modifications of plasma platelet-activating factor (PAF)- acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection 195
Host genetic determinants in HCV-related mixed cryoglobulinemia 190
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 184
Analysis of HCV persistence in patients with sustained virological response 184
Chronic hepatitis C and B-cell non-Hodgkin's lymphoma 181
Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment 177
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 177
Interferon and thymosin combination therapy in naive patients with chronic hepatitis C. Preliminary results 174
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 174
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? 172
Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients 171
Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab 169
HCV-related mixed cryoglobulinemia and BAFF promoter polymorphism 168
Involvement of PI3K in HCV-related lymphoproliferative disorders 167
Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia 166
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease 165
Hepatitis C virus as a lymphotropic agent: evidence and pathogenetic implications 164
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways. 164
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 164
Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection 163
T(14;18) translocation in chronic hepatitis C virus infection 162
HBV and HCV chronic infection: Autoimmune manifestations and lymphoproliferation 162
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression 161
Host genetic determinants in HCV-related mixed cryoglobulinemia 161
Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection. 160
HCV INFECTION OF PERIPHERAL AND LIVER MONONUCLEAR-CELLS - PATHOGENIC IMPLICATIONS 156
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 155
Applicazione della metodica PCR (polymerase chain reaction) ed altre tecniche di biologia molecolare allo studio dell'infezione da virus C dell'epatite. 155
Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role 155
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV 155
Hepatitis C virus core protein expression in human B-cell lines does not significantly modify main proliferative and apoptosis pathways 154
Tryptophan/kynurenine pathway changes in HCV-infected patients: possible involvement in associated neuropsychiatry pathology 152
A highly efficient, stable, and rapid approach for ex vivo human liver gene therapy via a FLAP lentiviral vector 151
HCV infection in mixed cryoglobulinemia and B-cell non-Hodgkin’s lymphoma. 150
Genetic determinants in Hepatitis C Virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fc-gamma receptors 147
Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. 146
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 145
Hepatitis C virus core protein enhances B lymphocyte proliferation 144
Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis 142
ANALYSIS OF HCV INFECTION IN PATIENTS WITH B-CELL NON-HODGKINS-LYMPHOMA 141
Efficacia del trattamento antivirale nell’indurre la regressione di cloni B cellulari alberganti la traslocazione t(14;18) nell’infezione cronica da virus C dell’epatite (HCV). 139
Tryptophan/Kynurenine pathway changes in HCV infected patients: possible involvment in associated neuropsychiathy pathology. 139
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 138
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 138
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated? 138
Safety and effectiveness of boceprevir triple therapy in patients with mixed cryoglobulinemia 135
Hepatitis C virus lymphotropism and possible pathogenetic implications 133
The role of the rs12979860 polymorphism of the interleukin-28b as predictor of spontaneus clearance of HCV infection in patients with hemophilia 133
Effects of depletion of B cell by anti-CD20 monoclonal antibody in HCV+ mixed cryoglobulinemia (MC) and liver cirrhosis 133
VALUE OF IL28B GENOTYPING IN PATIENTS WITH HCV-RELATED MIXED CRYOGLOBULINEMIA: RESULTS OF A LARGE, PROSPECTIVE STUDY 133
HCV infection and carotid atherosclerosis: evidence in favour of a local viral action inside the plaque 132
Il polimorfismo dell'interleuchina 28B come predittore di risposta in pazienti con crioglobulinemia mista HCV-correlata 132
Effect of antiviral treatment on the prevalence of BCL-2 recombination in HCV infected patients 132
Lack of preferential localization of tumoral mass in B-cell non-Hodgkin's lymphoma associated with hepatitis C virus infection 131
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 130
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 127
Tryptophan/kynurenine Patway Changes in HCV-infected Patients: Possible Involvement In Associated Neuropsychiatry Pathology 126
Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesis 126
Hepatitis C virus-related lymphoproliferative disorders: an overview 126
Characterization of uptake, degradation and toxicity of antisense ODNs in cancer cells. Characterization of uptake, degradation and toxicity of antisense ODNs in cancer cells 124
Frequency of bcl-2 rearrangement in patients with mixed cryoglobulinemia and HCV-positive liver diseases 124
Hepatitis C virus as a lymphotropic agent: Evidence and pathogenetic implications 124
Hepatitis C virus RNA localization in human carotid plaques. 124
Can depletion of B-cells by anti-CD20 monoclonal antibody in HCV plus mixed cryoglobulinemia (MC) improve liver cirrhosis? 123
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 122
E' possibile la trasmissione del virus C dell'epatite nei centri di dialisi mediante il passaggio attraverso la membrana emodialitica? Risultati di uno studio preliminare 122
The Hepatitis C Virus Infection as a Systemic Disease 121
Serum HCV-RNA and liver histologic findings in patients with long-term normal transaminases 121
HCV infection of mononuclear cells in chronic hepatitis and in mixed cryoglobulinaemia: possible pathogenetic implications. 120
Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis 119
Mixed cryoglobulinemia syndrome is a negative prognostic factor in the standard of care (Peg-IFN+ribavirin) anti-HCV therapy 119
HCV infection in B-cell non-Hodgkin's lymphoma 118
Is T(14;18)(q32;q21) translocation a hallmark of HCV-related mixed cryoglobulinemia? 116
Comparative analysis of two assays for genotyping hepatitis C virus based on genotype-specific primers or probes 115
Eventi Oncomolecolari nella Crioglobulinemia Mista 115
Hepatitis C virus lymphotrophism: lesson from a decade of studies 114
IL28B polymorphism as predictor of response to anti-HCV terapy in HCV-related mixed cryoglobulinemia syndrome 114
HCV infection in B-cell non-Hodgkin’s lymphoma. 114
Is t(14;18)(q32;q21) translocation a hallmark of HCV-related mixed cryoglobulinemia? 114
Effect of rituximab on advanced liver disease in patients with HCV-related mixed cryoglobulinemia. 112
Hepatitis C virus biology. 111
Prevalence of bcl-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. 111
Long-term outcome of HCV-related mixed cryoglobulinemia in patients achieving sustained viral sustained viral response (SVR) after antiviral therapy 111
Could HGV infection be implicated in lymphomagenesis? 109
Association between HCV infection and monoclonal gammopathy (MG): A putative role for genotype 2a? 109
Hepatotropic viruses: new insights in pathogenesis and treatment 108
HCV core protein induces B lymphocytes proliferation increasing DNP63 expression 108
HCV infection in B-cell non-Hodgkin's lymphoma 108
Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx 107
Gene modulation associated with inhibition of liver regeneration in hepatitis B virus X transgenic mice. 107
Hepatitis C virus infction of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients. 101
Il virus dell'epatite C (HCV): l'infezione e la malattia 100
Totale 14.805
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.835
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.835
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021124 0 0 0 0 0 0 0 0 0 0 68 56
2021/2022879 6 122 21 43 29 18 24 54 35 12 198 317
2022/20232.211 224 230 99 184 230 459 325 103 244 22 59 32
2023/2024658 43 99 145 41 50 83 17 132 7 11 12 18
2024/20255.735 166 591 364 834 2.065 608 74 383 267 94 163 126
2025/20264.373 643 710 309 205 521 181 646 242 569 281 66 0
Totale 17.655